No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
PFE240719C28000
- 1.55
- -0.47-23.27%
15min DelayClose Jul 18 16:00 ET
2.67High1.55Low
2.02Open2.02Pre Close860 Volume32.52K Open Interest28.00Strike Price200.30KTurnover158.66%IV-0.54%PremiumJul 19, 2024Expiry Date1.71Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.7955Delta0.1267Gamma15.01Leverage Ratio-0.3924Theta0.0005Rho11.94Eff Leverage0.0040Vega
Intraday
- 5D
- Daily
News
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
GLP-1 market leaders Eli Lilly and Company (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) faced a significant selloff on Thursday, as new weight-loss drugs from rival pharmaceutical companies began threatening the dominance of their flagship products, Zepbound and Wegovy.
Pfizer Options Spot-On: On July 18th, 266.35K Contracts Were Traded, With 2.96 Million Open Interest
On July 18th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 266.35K options for the day, of which put options accounted for 30.65% of the total transactions, and
COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
More than half of the states in the U.S. are experiencing significant Covid-19 activity in wastewater, and President Joe Biden remains in isolation after announcing Wednesday he caught the virus for
Valneava and Pfizer Nearing Lyme Vaccine Milestone
Pfizer/Valneva's Vaccine Study For Tick-Borne Infection Completes Primary Vaccination Series, Plans Approval In 2026
On Wednesday, Pfizer Inc (NYSE:PFE) and Valneva SE (NASDAQ:VALN) announced that the participants of the Phase 3 VALOR trial have completed the primary vaccination series (three doses) of Lyme disease vaccine candidate VLA15.
Express News | President Biden's Doctor Says President Biden's Vital Signs Remain Normal; He Will Continue To Conduct U.S. Business; Continues To Receive Paxlovid; Still Experiencing Mild Covid-19 Symptoms
Comments
$Pfizer(PFE.US$ this is the only healthcare share rise today . what’s happening to others
“History Doesn’t Repeat Itself, but It Often Rhymes” – Mark Twain
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful” – Warren Buffett
“Success means being very patient, but aggressive when it’s time.” – Charlie Munger
My previous posts,
I am looking forward to upcoming Fed cuts
Will Nvidia Pullback to 90 ?
$NVIDIA(NVDA.US$ $iShares Russell 2000 ETF(IWM.US$ $MarketAxess(MKTX.US$ $Pfizer(PFE.US$ $Vanguard Real Estate ETF(VNQ.US$ $Global Payments(GPN.US$
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful” – Warren Buffett
“Success means being very patient, but aggressive when it’s time.” – Charlie Munger
My previous posts,
I am looking forward to upcoming Fed cuts
Will Nvidia Pullback to 90 ?
$NVIDIA(NVDA.US$ $iShares Russell 2000 ETF(IWM.US$ $MarketAxess(MKTX.US$ $Pfizer(PFE.US$ $Vanguard Real Estate ETF(VNQ.US$ $Global Payments(GPN.US$
loading...
3
Why do you think $Pfizer(PFE.US$ decided to progress with Danuglipron? (![]()
Can't give up this huge market?
The P2 data they published in obese, non-diabetics doesn't look too good. Danuglipron twice daily compared with $Eli Lilly and Co(LLY.US$ Orforglipron and $Structure Therapeutics(GPCR.US$ GSBR 1290 at week 12: Orforglipron seems to be the best non-peptide GLP-1 RA
The P2 data they published in obese, non-diabetics doesn't look too good. Danuglipron twice daily compared with $Eli Lilly and Co(LLY.US$ Orforglipron and $Structure Therapeutics(GPCR.US$ GSBR 1290 at week 12: Orforglipron seems to be the best non-peptide GLP-1 RA
+1
5
Read more